Zydus Lifesciences settles US Patent Litigation with Astellas Pharma over Myrbetriq, to pay USD 120 million Corporates · Feb 12, 2026
Zydus Life shares jump over 4% as Q3 Revenue surge 30.3% YoY to Rs 6,864.5 crore, net profit rises 1.8% Stock Market · Feb 9, 2026
Zydus Lifesciences Q3 Results: Revenue jumps 30.3% YoY to Rs 6,864.5 crore, net profit up 1.8% Quarterly Results · Feb 9, 2026
Top Q3 results today, Feb 9: BSE, Zydus Lifesciences, Aurobindo Pharma, Pfizer and more to announce earnings Quarterly Results · Feb 9, 2026
Zydus Lifesciences receives USFDA tentative approval for Dapagliflozin Tablets Corporates · Feb 4, 2026
Stocks to watch today, Jan 27: Infosys, Adani Enterprises, Zydus Lifesciences, ONGC, Bank of Baroda and more Stock Market · Jan 27, 2026
Zydus Lifesciences launches world’s first biosimilar of Nivolumab, ‘Tishtha’ in India Corporates · Jan 22, 2026
Zydus Lifesciences’ US arm Sentynl secures FDA approval for ZYCUBO, first-ever treatment for Menkes disease Corporates · Jan 13, 2026
Zydus Lifesciences shares in focus today after High Court allows semaglutide manufacturing for exports Stock Market · Dec 23, 2025
Zydus Lifesciences signs exclusive agreement with Myriad Genetics to launch advanced cancer genomic tests in India Corporates · Dec 19, 2025
Top stocks to watch today, December 16: HCL Technologies, TCS, RBL Bank, Delhivery, Zydus Lifesciences and more Stock Market · Dec 16, 2025
Zydus Lifesciences launches ‘Zyrifa’, a Denosumab biosimilar for advanced cancer-related bone complications Corporates · Dec 10, 2025
Zydus Lifesciences receives EIR from USFDA for the injectable facility at Jarod Corporates · Dec 4, 2025
Top stocks to watch today, November 28: Adani Enterprises, Wipro, TCS, Tata Technologies, Zydus Lifesciences and more Stock Market · Nov 28, 2025
Zydus Lifesciences gets USFDA Tentative nod for Empagliflozin and Linagliptin tablets Corporates · Nov 27, 2025